IL-G-SQUARED
26.8.2024 15:01:35 CEST | Business Wire | Press release
G Squared, a growth-stage venture capital firm dedicated to supporting the capital needs of dynamic technology companies throughout their life cycles, today announced that it has raised $1.1B of committed capital for its sixth flagship fund, G Squared VI. In keeping with the firm’s long standing strategy, the majority of G Squared VI will be allocated to secondary market opportunities, providing growth capital and critical liquidity to the next generation of disruptive tech companies and their stakeholders.
G Squared VI aligns to a pivotal moment in the market as secondary transactions have soared to unprecedented levels in the first half of 2024, with volumes crossing the $70 billion mark. G Squared was founded in 2011 on the idea that as companies stay private longer, they will require a partner that understands and can address their unique liquidity needs – a trend playing out in real-time. The firm aims to deliver essential liquidity to stakeholders – including founders, early investors, and employees – facilitating value realization for all parties involved.
"We are thrilled to have closed this substantial fund, which reflects the trust and confidence our limited partners have in our team and our strategic vision," said Larry Aschebrook, Founder and Managing Partner of G Squared. "G Squared VI will enable us to continue our mission of partnering with transformative companies that are shaping the future, while also leveraging secondary market opportunities to provide liquidity relief for the VC ecosystem."
G Squared’s strategy relies on flexible deployment of capital through a full suite of liquidity services including direct secondary transactions, primaries and structured primaries, company-sponsored tenders, and more, working in partnership with portfolio company management teams to drive continued growth and stability in the private markets. With this significant capital infusion, G Squared aims to identify and support visionary entrepreneurs and the world's fastest-growing tech companies in the firm’s four core areas of focus: SaaS, fintech and insurtech, mobility, and consumer internet.
G Squared is a global company - a play on ‘global growth’ - and the firm will remain steadfast in its mission of partnering with the world’s best growth-stage tech companies through its distinctive investment principles, creating the conditions for pioneering leaders to shape the future through technology. With this additional capital in G Squared VI, G Squared now has approximately $4B under management and has deployed $5B in capital to support leading companies including Anthropic, Bolt, Coursera, Fanatics, FIGS, Tipalti, Toast, Turo, Uber, and Wiz.
About G Squared
G Squared is a global venture capital firm that partners with dynamic companies throughout their life cycles as a complete capital solutions provider, working to create value for companies, investors, employees, and other stakeholders. The firm focuses on investments in growth-stage technology companies and has invested in 130+ portfolio companies since it was founded in 2011. For more information on G Squared and its portfolio, visit: www.gsquared.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240826548473/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novatus Global Receives a King’s Award for Enterprise6.5.2026 08:00:00 CEST | Press release
Novatus Global Limited (“Novatus” “Novatus Global” or “the Company”), an award-winning provider of regulatory technology solutions and consulting services to global financial institutions, has been honoured with a King’s Award for Enterprise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505378016/en/ Novatus is one of only 185 organisations nationally to be recognised with a prestigious King’s Award for Enterprise in 2026. Announced today (Wednesday 6 May), the Award acknowledges the company’s outstanding achievement in Innovation. Novatus Global, founded in 2019, employs over 100 people across London, the U.S., Australia, and India and has rapidly established itself as a trusted partner to many of the world’s leading banks, asset managers, and financial institutions. Its flagship product, Novatus En:ACT, is a market-leading SaaS platform delivering complete, real-time assurance across global transaction reporting regim
Hisense Delivers 38% Sales Uplift in Western Europe Markets With NIQ’s AI-Powered Market Intelligence6.5.2026 05:00:00 CEST | Press release
NIQ insights drive international expansion and measurable growth for Hisense across key global markets NIQ (NYSE: NIQ), a global leader in consumer intelligence, today shared new learnings from its long-standing collaboration with Hisense, a leading global brand in home appliances and smart technologies. Using NIQ’s AI‑powered market intelligence, Hisense has accelerated international expansion, improved local market decision-making, and delivered measurable growth across more than 20 key markets and 12+ categories. The case study demonstrates how AI‑driven insights help global brands move faster, localize better, and compete more effectively in complex markets. The Challenge As Hisense expanded internationally, it faced rising complexity across global markets. Consumer preferences differed sharply across regions such as Western Europe, Eastern Europe, and Latin America, making a one‑size‑fits‑all approach ineffective. NIQ’s AI‑powered intelligence delivered the local market depth need
Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)6.5.2026 01:00:00 CEST | Press release
Phase 1 study has demonstrated pharmacokinetics (PK) equivalence between SB27 and KeytrudaPhase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 study on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), has met its primary pharmacokinetics (PK) endpoints. The randomized, double-blind, three-arm, parallel group, multicenter clinical trial demonstrated pharmacokinetic bioequivalence of SB27 (pembrolizumab) to the reference product Keytruda. Initiated in January 2024, Phase 1 study is being conducted in four countries, and is expected to be completed by November 2026.2 The study assessed pharmacokinetics, efficacy, safety, and immunogenicity of SB27, EU-sourced Keytruda, and US-sourced Keytruda in patients with stage II or IIIA non-small cell lung cancer (NSCLC) following complete resection and adjuvant platinum-based chemotherapy. 163 participants were randomized to receive SB27, EU-sourced Keytruda, or US-sour
Megaport Launches Built-In DDoS Protection Enabling On-Demand Network Resilience6.5.2026 00:00:00 CEST | Press release
Megaport DDoS Protection removes the trade-off between security, performance, and cost, offering rapid enterprise-grade mitigation. Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of Megaport DDoS Protection. This new, built-in security capability for Megaport Internet allows customers to filter malicious traffic directly within the Megaport network rather than routing it through a separate or external service, for mission-critical uptime without introducing additional latency or routing complexity. As enterprises increasingly migrate to distributed cloud environments, traditional DDoS mitigation has struggled to keep pace with cloud and distributed infrastructure adoption. Standard ISP solutions often resort to dropping all traffic and taking the service offline to protect the network, while external third-party providers force a "security detour" that reroutes traffic through public infrastructure, introducing s
IFF Reports First Quarter 2026 Results5.5.2026 22:23:00 CEST | Press release
Delivered solid top and bottom line Q1 resultsProgressing disciplined sale process for Food Ingredients businessReaffirms Full Year 2026 Financial Guidance IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Consolidated Summary: Management Commentary “IFF is off to a solid start in 2026, with first quarter results that reflect the customer focus and operational execution we’ve been building across the company,” said Erik Fyrwald, CEO of IFF. “We delivered volume growth in all four segments, improved profitability, and generated strong cash flow in the first quarter. As we look ahead, we are maintaining a disciplined approach to how we are planning the balance of the year as the current operating environment remains unsettled. We remained focused on advancing our commercial and innovation pipelines, driving productivity, and working with customers to offset inflation. This – when combined with our solid start to the year – derisks t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
